麻豆传媒

Meeting Coverage >

TCT

Aortic Regurgitation Device Passes in Pivotal Trial

JenaValve device hits benchmarks with improvement in pacemaker rates

Combining TAVR, LAA Closure in Same Procedure Safe, Trial Says

WATCH-TAVR suggests percutaneous approach can follow surgical pattern in not staging procedures

Amulet vs Watchman Comparison Still Muddy Any Which Way LAA Leaks Are Defined

The two devices continue to lead to similar clinical outcomes

Low-Risk TAVR Converging or Diverging With Surgical Outcomes, Depending on the Valve

Intermediate-term reports from PARTNER 3 and Evolut Low Risk trials

PCSK9 Inhibitor Passes Muster for LDL Reduction in Acute Coronary Syndrome

Question now is whether routine early treatment will translate to better clinical outcomes

Brief Anticoagulation Preserves Radial Artery After Catheter Access

Trial shows promise of a short course of direct-acting oral anticoagulant

PCI vs CABG: Does Age Inform Choice for Left Main Coronary Artery Disease?

Swedish registry study contributes to ongoing controversy

Pulmonary Artery Denervation Improves PAH Symptoms

Trial promising for novel technique

RDN Powers Through Another Off-Med Trial, Clinical Benefits Still Untested

Plus, an apparent magnification of effect in SYMPLICITY HTN-3

PCI Not (Much) Worse Than CABG for Multivessel Disease Long Term

Extended follow-up of BEST trial appeared unlikely to change minds, though

Ultrasound Guidance No Advantage for PCI Access

But randomized trial still suggests some reasons to consider this readily available intervention

MitraClip G4 Sets the Bar Higher for Transcatheter Edge-to-Edge Repair

Post-approval study suggests growing pool of TEER-suitable patients

Clot Grabber Safe, Promising in Intermediate-Risk PE

Registry supports expanding use of interventional treatment

Post-MI Ventricular Septal Defect Repair Strategies: Each Has Its Place for Now

Registry study compares percutaneous vs surgical outcomes in real-world practice

Is TAVR in Small Aortic Annuli Better With Self-Expanding Valves?

Registry supports mortality impact of patient-prosthesis mismatch

Mitral Valve Repair Devices Go Head-to-Head, and the Top Spot Belongs to...

CLASP IID trial crowns no winner but champions expanding choices

Presumed Clinical Benefits of TAVR Cerebral Protection Remain Unproven

Large trial comes up short in proving a definitive benefit to debris filters

DCBs for the Coronaries: Early Victories for New Drug Coatings

Researchers eye next gen drug-coated balloons despite lack of FDA OK for use in PCI

Gastrointestinal Damage Nearly Universal With Antiplatelet Use After PCI

Noninvasive endoscopy in OPT-PEACE reveals surprises about GI effects of antiplatelets

Pulmonary Pressure Monitoring Helps HFpEF Too

GUIDE-HF substudy supports similar benefits across the ejection fraction spectrum

Is LAA Closure With Amulet Less Leaky?

Two studies, IDE and SWISS-APERO, come to disparate conclusions

Short DAPT Just as Good for High-Bleeding Risk Stenting After MI

MASTER-DAPT is "good news" on a the key clinical concern

Longstanding Vascular Closure Technique Triumphs Over Collagen Plug

Manta versus ProGlide after transfemoral TAVR in CHOICE-CLOSURE

TAVR Chugging Along at 5 Years in SURTAVI Trial

Plus, data suggest that it is probably cost-effective in low-risk patients

LAA Closure Holds Up Against NOACs

Longer-term follow-up from the PRAGUE-17 trial reassures

TAVR Operators Divided on Need for Bicuspid RCT

Odds of a study coming to fruition are low

Adenosine-Free Alternative to FFR Bolstered by Longer-Term Data

Physiological index boasts good 5-year results in iFR-SWEDEHEART

No-Pressure-Wire Physiology Boosts PCI Outcomes

Chinese trial shows advantage over visual assessment alone

Surgery Keeps Edge Over Contemporary Stenting for Multivessel CAD

Large noninferiority margin still not enough in FAME 3 trial

Novel Stent Gets 'Sweet' Victory in Diabetes Patients

SUGAR trial shows superiority of polymer-free stent eluting fatty acid-bound sirolimus

No Aspirin Post-STEMI Stent; Sapien 3 Stroke Risk; and More

It's a TICO-STEMI, SOLVE-TAVI, FLASH, and IREMMI trial data round-up

'Drug-Based Therapy is Here to Stay' in Angioplasty for PAD

TCT Connect studies report reassuring safety data, promise in challenging segments

TAVR For Failing TAVR Doesn't Impress in Registry Data

5 year data for TAVR after SAVR looks "more optimistic"

Sobering Efficacy Data for TriGuard 3 Deflector in TAVR

Randomized trials on embolic protection devices are ongoing

COVID Heart Autopsies Point More to Clot Damage Than Myocarditis

Results bolster case for anticoagulation in hospitalized patients

ACS Patients Benefit From Bivalirudin During PCI, Pooled Data Show

Risks can be mitigated with infusion strategy, patient-level meta-analysis finds

Registry: Door-to-Balloon Times No Slower in COVID-19 Patients

North American registry shows worse outcomes even so

Is PCI the Answer to Vulnerable Plaques That Don't Limit Flow?

Some success with BVS placement in PROSPECT ABSORB

OCT Vs FFR: Which Is the Better Guide for Revascularization?

Optical coherence tomography goes up against physiological guidance in angiographically intermediate coronary lesions

TAVR at 5 Years: Paravalvular Regurgitation is Key

"No matter what you're using, you have to decrease PVR"

1